CD8A and neoplasm: To evaluate the behavior of Foxp3UP CD8 T cells in ACT schedules, mock (CD90.1+) and Foxp3UP (GFP+) OT-I cells were mixed (1:1) and transferred into B16OVA tumor-bearing mice (Figure 1C).